Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Ceribell

Explore full profile

Novel approach to acquiring and interpreting electroencephalography (EEG) data​

Mountain View, United StatesFounded 2014Health Tech & Medtech
Valuation $250–500M Last recorded · 2022
Revenue $50–100M Latest reported FY
Headcount 100–500 Current team size
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Ceribell and the history behind them.

About Ceribell

Ceribell is a healthcare technology startup that operates in the medical device market, specifically focusing on electroencephalogram (EEG) technology. The company's primary product is the Ceribell EEG Headband and Recorder, which are designed to be used by trained healthcare providers in a professional healthcare facility environment. The devices are used to monitor brain activity, a critical aspect of diagnosing and treating neurological conditions.

The company's business model revolves around the sale of these devices to healthcare providers. It's important to note that the Ceribell EEG Recorder does not provide any diagnostic conclusion about the patient’s condition, nor does it provide any automated alerts of an adverse clinical event. Instead, it serves as a tool for healthcare professionals to gather data, which they can then interpret and use to guide treatment decisions.

The company's products are particularly relevant in situations where time to treatment is critical, as the devices can help to quickly gather data on a patient's brain activity. This can be crucial in cases of Nonconvulsive Status Epilepticus (NCSE), a condition where a seizure lasts for an extended period, as morbidity and mortality rates increase with prolonged NCSE.

In terms of financials, Ceribell makes money by selling its EEG devices to healthcare providers. The devices are restricted for sale by or on the order of a physician, as per US federal law.

Source: Dealroom company data

At a glance

Founded
2014
Headquarters
Mountain View, United States
Sector
Health Tech & Medtech
Power Law
Colt$25–100M revenue

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

  • DHVC (Danhua Capital)
  • ShangBay Capital
  • The Rise Fund (TPG)
  • LivaNova
  • UCB

Series B and later6 investors entered at this stage

  • Horizon Technology Finance Corporation
  • Longitude Capital
  • Red Tree Venture Capital
  • Redmile Group
  • RA Capital Management
  • Ally Bridge Group
Team profiled 14 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇺🇸 United States99.3%
🇨🇳 China0.3%
🇨🇦 Canada0.3%
3 countries shown
Web traffic by country
44K monthly visits
across markets
🇺🇸 United States96.1%
🇮🇳 India3%
🇵🇭 Philippines1.8%
Top 3 markets shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Ceribell on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Ceribell on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.